Panel Discussion: Translating Modality Into Value for Patients to Establish Clearly Defined Clinical Objectives

Time: 1:30 pm
day: CONFERENCE DAY ONE

Details:

  • Building on the industry’s failures to re-evaluate how to select and measure the right clinical outcome
  • Steering the direction of research to acquire robust data that can illustrate clinical translatability and expedite discovery towards Phase I of clinical trials
  • Positioning patients at the heart of the modality to demonstrate its viability, thereby eliminating the need for a cost-risk analysis

Speakers: